Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine

Scope & Guideline

Connecting Researchers and Practitioners in Clinical Medicine

Introduction

Welcome to the Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1179-5484
PublisherSAGE PUBLICATIONS LTD
Support Open AccessYes
CountryNew Zealand
TypeJournal
Convergefrom 2010 to 2011, from 2013 to 2023
AbbreviationCLIN MED INSIGHTS-CI / Clin. Med. Insights-Circ. Respir Pulm. Med.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The journal 'Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine' focuses on advancing knowledge and understanding in the fields of circulatory, respiratory, and pulmonary medicine. Its aim is to publish high-quality, peer-reviewed research that contributes to clinical practice and improves patient outcomes. The journal encompasses various methodologies including systematic reviews, cohort studies, and clinical trials, highlighting its commitment to evidence-based medicine.
  1. Respiratory Diseases and Conditions:
    The journal covers a wide range of respiratory diseases, with a significant focus on acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), and various infectious diseases like pneumonia, particularly in the context of emerging pathogens such as SARS-CoV-2.
  2. Cardiovascular Health and Disease:
    Research related to cardiovascular complications associated with respiratory conditions is a core area, including studies on pulmonary hypertension, cardiogenic shock, and the interplay between respiratory and cardiovascular systems.
  3. Innovative Clinical Interventions:
    The journal emphasizes studies that explore novel therapeutic interventions and management strategies for respiratory and circulatory conditions, including the use of extracorporeal life support (ECLS) and advanced imaging techniques.
  4. Impact of Comorbidities:
    There is a strong focus on how comorbid conditions influence respiratory and circulatory health, with particular attention to the effects of diabetes, cancer, and systemic diseases on pulmonary outcomes.
  5. Epidemiological Studies and Public Health:
    The journal publishes research that assesses the prevalence, outcomes, and public health implications of respiratory diseases, particularly in the context of global health crises like the COVID-19 pandemic.
Recent publications in the journal have revealed several trending and emerging themes that are gaining traction in the field of circulatory and respiratory medicine. These themes reflect current healthcare challenges and advancements in research methodologies.
  1. Impact of COVID-19 on Respiratory Health:
    The ongoing research into the effects of COVID-19 on respiratory health, including the long-term consequences of infection and management strategies for acute respiratory distress, has become a dominant theme in recent publications.
  2. Use of Early Warning Systems in Clinical Settings:
    There is an emerging focus on the implementation and efficacy of early warning scoring systems (EWSS) in clinical practice, particularly for managing exacerbations in COPD and other respiratory conditions.
  3. Thromboembolic Complications in Respiratory Disease:
    The investigation of thromboembolic events, especially in the context of COVID-19 and its associated complications, has gained importance, reflecting a broader understanding of the interplay between respiratory and vascular health.
  4. Innovations in Therapeutic Approaches:
    Recent studies highlight innovative therapeutic interventions, such as the use of monoclonal antibodies and extracorporeal life support in severe cases, indicating a trend towards personalized and advanced treatment options.
  5. Multisystem Effects of Respiratory Conditions:
    Research exploring the multisystem effects of respiratory diseases, particularly in critically ill patients, is on the rise, emphasizing the interconnectedness of respiratory health with overall patient outcomes.

Declining or Waning

As the journal has evolved, certain themes have seen a noticeable decline in prominence. This section identifies these waning scopes, reflecting a shift in research focus and priorities within the journal's publications.
  1. Neoplastic Respiratory Conditions:
    Research related to neoplastic conditions such as lung cancer has been less frequently highlighted in recent publications, suggesting a shift towards more acute and infectious respiratory conditions.
  2. Chronic Respiratory Disease Management:
    There appears to be a decrease in studies focusing on long-term management strategies for chronic respiratory diseases, such as asthma and COPD, which may be overshadowed by the urgent need to address acute respiratory infections.
  3. Traditional Diagnostic Techniques:
    The prevalence of research centered on traditional diagnostic methods for respiratory conditions has diminished, likely due to the increasing interest in advanced imaging and biomarker studies.
  4. Smoking Cessation Interventions:
    While smoking-related research was once a significant theme, recent publications indicate a waning interest in smoking cessation strategies, possibly reflecting a broader public health focus on infectious disease management.

Similar Journals

Annals of the American Thoracic Society

Transforming respiratory medicine with timely and relevant contributions.
Publisher: AMER THORACIC SOCISSN: 1546-3222Frequency: 12 issues/year

Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.

Zeitschrift fur Pneumologie

Transforming Insights into Clinical Practice
Publisher: SPRINGER HEIDELBERGISSN: 2731-7404Frequency: 6 issues/year

Zeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.

BMJ Open Respiratory Research

Advancing respiratory health through innovative research.
Publisher: BMJ PUBLISHING GROUPISSN: Frequency: 1 issue/year

BMJ Open Respiratory Research is a prestigious open access journal published by the BMJ Publishing Group, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2014, the journal has provided a vital platform for the dissemination of innovative research and clinical findings, boasting an impressive Q1 ranking in its category as of 2023. With a Scopus rank of #35 out of 155 in Pulmonary and Respiratory Medicine, BMJ Open Respiratory Research is recognized for its high-quality content, engaging a global audience of researchers, healthcare professionals, and students. The journal embraces an open access model, ensuring that groundbreaking research is readily available to the community and stakeholders, thereby accelerating knowledge exchange and improving patient care. By focusing on diverse aspects of respiratory health, this journal plays a crucial role in shaping the future of respiratory research and practice.

Respiratory Investigation

Transforming insights into impactful respiratory solutions.
Publisher: ELSEVIERISSN: 2212-5345Frequency: 6 issues/year

Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.

Lung India

Elevating standards in lung disease management.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0970-2113Frequency: 6 issues/year

Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.

Respiratory Care

Connecting Research with Real-World Respiratory Care.
Publisher: DAEDALUS ENTERPRISES INCISSN: 0020-1324Frequency: 12 issues/year

Respiratory Care is a leading journal in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, published by DAEDALUS ENTERPRISES INC. With a history dating back to 1973 and continuing through 2024, this journal serves as a vital platform for disseminating innovative research findings, clinical practices, and advancements in respiratory healthcare. The journal is recognized for its impact, reflected in its impressive Q2 quartile rankings across several categories in 2023, demonstrating its relevance and influence in the medical community. Although it is not an Open Access publication, it provides critical insights and foster discussions aimed at enhancing patient care and treatment protocols for respiratory diseases. The journal is indexed in notable databases, ensuring wide visibility and accessibility of its content to researchers, professionals, and students dedicated to advancing knowledge and practice in respiratory care.

BMC Pulmonary Medicine

Advancing respiratory health through open access research.
Publisher: BMCISSN: 1471-2466Frequency: 1 issue/year

BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.

Chronic Respiratory Disease

Transforming insights into improved patient care.
Publisher: SAGE PUBLICATIONS LTDISSN: 1479-9723Frequency: 1 issue/year

Chronic Respiratory Disease is a leading peer-reviewed journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by SAGE Publications Ltd since its inception in 2004, this open-access journal has been at the forefront of disseminating high-quality research aimed at addressing chronic respiratory conditions. With an impressive impact factor and classified as Q1 in the 2023 category of Pulmonary and Respiratory Medicine, it ranks an admirable #45 out of 155 in Scopus, placing it in the 71st percentile of its field. This journal features a diverse range of studies, reviews, and clinical insights that cater to researchers, healthcare professionals, and students alike, encouraging the exchange of innovative ideas and practices in respiratory disease management. Operating out of London, UK, Chronic Respiratory Disease exemplifies a commitment to openness, having transitioned to open access since 2017, thereby ensuring that pivotal research is readily accessible to a global audience engaged in the improvement of respiratory health.

RESPIRATORY RESEARCH

Leading the Charge in Respiratory Health Advancements
Publisher: BMCISSN: Frequency: 1 issue/year

RESPIRATORY RESEARCH is a leading open-access journal published by BMC, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2000, this journal has provided a vital platform for disseminating high-quality research, covering a broad spectrum of topics from basic science to innovative clinical practices in respiratory health. With an impressive impact factor and a Q1 ranking in the Pulmonary and Respiratory Medicine category, RESPIRATORY RESEARCH is recognized for its significant contribution to the literature, currently positioned at rank #19 out of 155 in the Scopus database, highlighting its relevance and influence within the medical community. The journal’s commitment to open access ensures that all articles are freely available to researchers, professionals, and students, fostering collaboration and knowledge sharing in the field. With its convergence years spanning from 2000 to 2024, RESPIRATORY RESEARCH remains at the forefront of respiratory medicine research, making it an essential resource for all stakeholders in this vital medical domain.

Turkish Thoracic Journal

Elevating respiratory medicine with open-access discoveries.
Publisher: AVESISSN: Frequency: 6 issues/year

Turkish Thoracic Journal, published by AVES, is a prominent open-access platform dedicated to advancing the field of pulmonary and respiratory medicine. Since its establishment, the journal has aimed to disseminate significant research findings, clinical studies, and reviews that contribute to an improved understanding of respiratory health challenges, with a particular focus on the Turkish context and regional issues. With an E-ISSN of 2149-2530 and transitioning to open access in 2022, the journal enhances visibility and accessibility, inviting a global audience of researchers, clinicians, and students to engage with the latest scientific work. The Turkish Thoracic Journal has been indexed in major databases, although it faced a coverage discontinuation in Scopus between 2016 and 2022. Currently positioned within the 23rd percentile among its peers in the field, it invites submissions that explore innovative approaches to thoracic health, enriching the discourse in a vital area of medicine.